Aims & Scope

Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports.

MDR coverage includes:

  • Molecular biology of resistance mechanisms
  • Virulence genes and disease
  • Molecular epidemiology
  • Drug design
  • Infection control

Microbial Drug Resistance is under the editorial leadership of Editor Alexander Tomasz, PhD, The Rockefeller University, Laboratory of Microbiology, and other leading investigators. View the entire editorial board.

Audience: Molecular biologists, cell biologists, viral immunologists, microbiologists, viral infection pathologists, among others

Indexed/Abstracted in:



PubMed Central;

Current Contents®/Life Sciences;

Current Contents®/Clinical Medicine;

Science Citation Index Expanded;

Science Citation Index®;

Biological Abstracts;

BIOSIS Previews;

Journal Citation Reports/Science Edition;

Prous Science Integrity®;

ISI Custom Information Services;

EMBASE/Excerpta Medica;


ProQuest databases;

CAB Abstracts;

Global Health;

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.